WallStreetZenWallStreetZen

NASDAQ: ALMS
Alumis Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ALMS

Based on 3 analysts offering 12 month price targets for Alumis Inc

Min Forecast
$15.00+219.15%
Avg Forecast
$24.00+410.64%
Max Forecast
$32.00+580.85%

Should I buy or sell ALMS stock?

Based on 3 analysts offering ratings for Alumis Inc.

Buy
Strong Buy
0 analysts 0%
Buy
3 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ALMS's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates ALMS as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their ALMS stock forecasts and price targets.

ALMS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-26
lockedlocked$00.00+00.00%2025-01-30
lockedlocked$00.00+00.00%2024-10-31

1 of 1

Forecast return on equity

Is ALMS forecast to generate an efficient return?

Company
-78.86%
Industry
153.19%
Market
81.87%
ALMS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ALMS forecast to generate an efficient return on assets?

Company
-60.15%
Industry
36.07%
ALMS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ALMS earnings per share forecast

What is ALMS's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$4.27
Avg 2 year Forecast
-$3.89
Avg 3 year Forecast
-$3.86

ALMS revenue forecast

What is ALMS's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$20.0M
Avg 2 year Forecast
$33.5M
Avg 3 year Forecast
$117.7M

ALMS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ALMS$4.70$24.00+410.64%Buy
MBX$7.64$41.00+436.65%Strong Buy
ITOS$6.62$26.00+292.75%Strong Buy
SEPN$5.87$33.00+462.18%Strong Buy
MNPR$42.71$62.67+46.73%Strong Buy
View Top Biotech Stocks

Alumis Stock Forecast FAQ

Is Alumis Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ALMS) stock is to Buy ALMS stock.

Out of 3 analysts, 0 (0%) are recommending ALMS as a Strong Buy, 3 (100%) are recommending ALMS as a Buy, 0 (0%) are recommending ALMS as a Hold, 0 (0%) are recommending ALMS as a Sell, and 0 (0%) are recommending ALMS as a Strong Sell.

If you're new to stock investing, here's how to buy Alumis stock.

What is ALMS's earnings growth forecast for 2025-2027?

(NASDAQ: ALMS) Alumis's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.17%.

Alumis's earnings in 2025 is -$294,233,000.On average, 5 Wall Street analysts forecast ALMS's earnings for 2025 to be -$232,319,286, with the lowest ALMS earnings forecast at -$297,064,005, and the highest ALMS earnings forecast at -$184,440,839. On average, 3 Wall Street analysts forecast ALMS's earnings for 2026 to be -$211,824,046, with the lowest ALMS earnings forecast at -$282,374,027, and the highest ALMS earnings forecast at -$156,149,028.

In 2027, ALMS is forecast to generate -$210,191,826 in earnings, with the lowest earnings forecast at -$333,516,915 and the highest earnings forecast at -$84,331,357.

What is ALMS's revenue growth forecast for 2025-2028?

(NASDAQ: ALMS) Alumis's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.37%.

Alumis's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast ALMS's revenue for 2025 to be $1,088,146,540, with the lowest ALMS revenue forecast at $1,088,146,540, and the highest ALMS revenue forecast at $1,088,146,540. On average, 2 Wall Street analysts forecast ALMS's revenue for 2027 to be $1,822,808,676, with the lowest ALMS revenue forecast at $1,468,997,829, and the highest ALMS revenue forecast at $2,176,619,524.

In 2028, ALMS is forecast to generate $6,402,382,205 in revenue, with the lowest revenue forecast at $2,173,572,714 and the highest revenue forecast at $10,631,191,696.

What is ALMS's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ALMS) forecast ROA is -60.15%, which is lower than the forecast US Biotechnology industry average of 36.07%.

What is ALMS's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ALMS price target, the average ALMS price target is $24.00, with the highest ALMS stock price forecast at $32.00 and the lowest ALMS stock price forecast at $15.00.

On average, Wall Street analysts predict that Alumis's share price could reach $24.00 by Mar 26, 2026. The average Alumis stock price prediction forecasts a potential upside of 410.64% from the current ALMS share price of $4.70.

What is ALMS's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ALMS) Alumis's current Earnings Per Share (EPS) is -$10.38. On average, analysts forecast that ALMS's EPS will be -$4.27 for 2025, with the lowest EPS forecast at -$5.46, and the highest EPS forecast at -$3.39. On average, analysts forecast that ALMS's EPS will be -$3.89 for 2026, with the lowest EPS forecast at -$5.19, and the highest EPS forecast at -$2.87. In 2027, ALMS's EPS is forecast to hit -$3.86 (min: -$6.13, max: -$1.55).

What is ALMS's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ALMS) forecast ROE is -78.86%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.